MTAP is also commonly deleted in glioblastoma (40%), melanoma (25%), and pancreatic adenocarcinoma (25%);37–40 unlike NPC however, those cancers are commonly TP53-mutated. This evidence concerns the gene TP53 and nasopharyngeal carcinoma.